Luxiq (betamethasone valerate) Foam

Company
Connetics Corporation

Approval Status
Approved June 1999

Treatment for
Dermatology

Areas
Dermatology / Plastic Surgery

Luxiq (betamethasone valerate) Foam has been approved for the treatment of dermatoses of the scalp.

Luxiq Drug Information

The Luxiq drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top